Neuroleptics and the neuroleptic‐induced deficit syndrome

Acta Psychiatrica Scandinavica

Volumn 89, Issue , 1994, Pages 8-13

  Lewander, T ^a,b  

^a Astra Arcus AB   (Sweden)

^b UPPSALA UNIVERSITY   (Sweden)

Author keywords

antipsychotics; deficit syndrome; neuroleptics; psychosis; schizophrenia

Indexed keywords

CHLORPROMAZINE; FLUPHENAZINE; HALOPERIDOL; LEVOMEPROMAZINE; NEUROLEPTIC AGENT; PERPHENAZINE; THIORIDAZINE; TRIFLUOPERAZINE;

CONFERENCE PAPER; HUMAN; MENTAL DEFICIENCY; NEUROLEPTIC MALIGNANT SYNDROME; SCHIZOPHRENIA; SEDATION; SIDE EFFECT; AROUSAL; DRUG EFFECT; DYSKINESIA; EMOTIONAL DISORDER; IATROGENIC DISEASE; MOTIVATION; NEUROLOGIC EXAMINATION; PSYCHOLOGICAL ASPECT; PSYCHOSIS; REVIEW; SYNDROME;

AFFECTIVE SYMPTOMS; ANTIPSYCHOTIC AGENTS; AROUSAL; CHLORPROMAZINE; DYSKINESIA, DRUG-INDUCED; HUMAN; MOTIVATION; NEUROLOGIC EXAMINATION; PSYCHOTIC DISORDERS; SYNDROME;

EID: 0028267552     PISSN: 0001690X     EISSN: 16000447     Source Type: Journal    
DOI: 10.1111/j.1600-0447.1994.tb05825.x     Document Type: Article

References (59)

1. Psychophysiologic aspects of the new chemo‐therapeutic drugs in psychiatry
2. Antideficit properties of neuroleptics
3. Drugs and treatment of psychiatric disorders
4. Discovery of the clinical use of neuroleptics
5. Clinical observations on the actions of neuroleptics
6. Clozapine. A novel antipsychotic agent
7. Clinical profile of remoxipride‐ a combined analysis of a comparative double‐blind multicentre trial programme
8. Psychopathologische Wirkungen des Phenothiaz‐inderivates “Largactil” (=“Megaphen”) im Selbstversuch und bei Kranken
9. The psychopharniacology of phenothiazine compounds: a comparative study of the effects of chlorpromazine. proniethazine, triflu‐operazine, and perphenazine in normal males. 11. Results and discussion
10. Sedation and tranquillization
11. Effect of haloperidol on a symbol digit substitution task in normal adult males
12. Clinical pharmacology of antipsychotic drugs
13. Psychotropic and narcotic drugs and quality of life
14. Dopamine receptor subtypes and arousal
15. Antipsychotic drug mechanisms and neurotransmitter systems in schizophrenia
16. Preclinical findings with new antipsychotic agents: what makes them atypical
17. Why do schizophrenic patients refuse to take their drugs
18. Akinetic depression” in schizophrenia
19. Causes of neuroleptic non‐compliance
20. Subjective response to neuroleptics and the quality of life: implications for treatment outcome
21. Neuroleptic induced deficit syndrome: old problem, new challenge
22. Neuroleptic dysphoria: So what's new
23. Dyskognitive, apathische und ex‐trapyramidale Syndrome bei Langzeit‐Neurolepsie
24. Behavioural toxicity of antipsychotic drugs
25. Neuroleptic dysphoria
26. Is neuroleptic dysphoria a healthy response
27. The many faces of akathisia
28. Subjective response as a predictor of outcome in pharniacotherapy
29. A self‐report scale predictive of drug conipliance in schizophrenics: reliability and discriminative validity
30. A comparative study of haloperidol and chlorpromazine in terms of clinical effects and therapeutic reversal with benztropine in schizophrenia. Theoretical implications for potency differences aniong neuroleptics
31. Positive and negative schizophrenia symptoms and the role of dopamine
32. Deficit and nondeficit forms of schizophrenia: the concept
33. Neuroleptic treatment of negative symptoms in schizophrenic patients. Efficacy problems and niethodological difficulties
34. Negative and deficit symptoms in schizophrenia do respond to neuroleptics
35. The effect of neuroleptics and other psychotropic drugs on negative symptoms in schizophrenia
36. Depression, parkinsonian symptoms and negative symptoms in schizophrenia treated with neuroleptics
37. Motor and mental aspects of acute extrapyramidal syndromes
38. The schedule for the deficit syndrome: an instrument for research in schizophrenia
39. Über die Stellungsnahine auf abgelaufenen akuten Psychose
40. Depression in acute schizophrenic psychosis
41. Depressive syndrome im Verlauf neuroleptischer Therapic
42. Postpsychotic depression in schizophrenia
43. An investigation of the postpsychotic depressive syndrome
44. Dysphoric response to neuroleptic treatment in schizophrenia: its relationship to autonomic arousal and prognosis
45. Haloperidol in normals
46. Die Wirkung einer einmialigen Lar gactilgabe bei Gesunden
47. A medical student's experience with akathisia
48. Haloperidol induced dysphoria in patients with Tourette syndrome
49. Neuroleptic depression in schizophrenia
50. Subtle and underrecognized side effects of neuroleptic treatment in children with Tourctte's disorder